Contents hide 1 Non-Small Cell Lung Cancer 2 Dosage Modifications Capmatinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply. This helps slow or stop the spread of cancer cells. Non-Small Cell Lung Cancer Indicated for metastatic non-small cell lung cancer (NSCLC) in adults whose tumors have a mutation that leads to mesenchymal-epithelial transition (MET) exon 14 skipping 400 mg PO BID Continue until disease progression or unacceptable toxicity Dosage Modifications Dose reductions for adverse reactions First occurrence: Restart at 300 mg PO BID Second … Continue reading CAMPMADX (Capmatinib)